Toward a Universal Map of EEG: A Semantic, Low-Dimensional Manifold for EEG Classification, Clustering, and Prognostication.

OBJECTIVE

Prognostication in patients with disorders of consciousness (DOCs) remains challenging because of heterogeneous etiologies, pathophysiologies and, consequently, highly variable electroencephalograms (EEGs). Here, we use EEG patterns that are well-characterizable to create a latent map that positions novel EEGs along a continuum. We asses this map as a generalizable tool to extract prognostically valuable information from long-term EEG, by predicting outcome post-cardiac arrest as a first use case.

METHODS

Categorizable EEGs across the health-disease continuum (wake [W], sleep [rapid eye movement (REM), non-REM (N1, N2, N3)], ictal-interictal-continuum [lateralized and generalized periodic discharges (LPD, GPD) and lateralized and generalized rhythmic delta activity (LRDA, GRDA)], seizures [SZ], burst suppression [BS]; 20,043 patients, 288,986 EEG segments) are arranged meaningfully in a low-dimensional space via a deep neural network, resulting in a universal map of EEG (UM-EEG). We assess prognostication after cardiac arrest (576 patients, recovery or death) based on long-term EEGs represented as trajectories in this continuous embedding space.

RESULTS

Classification of out-of-sample EEG match state-of-the-art artificial intelligence algorithms while extending it to the currently largest set of classes across the health-disease continuum (mean area under the receiver-operating-characteristic curve [AUROCs] 1-vs-all classification: W, 0.94; REM, 0.92; N1, 0.85; N2, 0.91; N3, 0.98; GRDA, 0.97; LRDA, 0.97; SZ, 0.87; GPD, 0.99; LPD, 0.97; BS, 0.94). UM-EEG enables outcome prediction after cardiac arrest with an AUROC of 0.86 and identifies interpretable factors governing prognosis such as the distance to healthy states over time.

INTERPRETATION

UM-EEG presents a novel and physiologically meaningful representation to characterize brain states along the health-disease continuum. It offers new opportunities for personalized, long-term monitoring and prognostication. ANN NEUROL 2025;98:357-368.